HUMANA INC (HUM) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — HUM

Balance Sheet

(in billions USD)

Metric	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	4.95	5.39	4.04	4.25	5.12	5.50	5.91	15.15	16.21	13.74	13.56	5.15	4.86	4.30	3.38	3.88
Short-term Investments	17.01	16.74	17.67	17.89	19.03	17.42	16.70	15.15	15.25	14.93	13.12	13.04	13.09	13.72	13.47	13.25
Total Current Assets	38.08	32.75	33.62	34.42	32.93	32.86	32.80	38.25	38.76	37.53	33.71	27.22	26.84	25.82	25.79	25.53
Total Assets	55.28	49.72	50.36	50.93	50.01	50.09	50.09	55.91	56.46	54.78	50.77	46.82	46.31	45.32	38.07	37.42
Total Current Liabilities	21.51	16.18	17.22	18.04	18.73	19.79	19.69	27.82	28.28	26.94	25.05	17.84	17.53	15.03	15.05	15.30
Long-term Debt	12.27	12.61	12.59	12.73	11.89	11.75	12.39	9.48	9.72	9.74	7.80	11.29	11.29	11.47	6.06	6.06
Total Liabilities	36.63	31.14	32.06	33.11	32.38	33.37	33.91	38.90	39.56	38.14	34.45	31.31	30.97	29.04	23.23	23.23
Retained Earnings	30.15	29.98	29.89	29.45	29.12	28.75	28.17	28.19	27.47	26.62	25.61	24.51	23.92	23.19	21.75	21.25
Total Stockholder Equity*	18.58	18.52	18.23	17.75	17.57	16.67	16.13	16.95	16.83	16.58	16.32	15.51	15.34	16.28	14.84	14.19

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Net Premiums Earned	37.71	30.88	30.71	30.72	30.51	27.75	27.95	28.14	28.26	25.13	25.10	25.50	25.55	21.28	21.47	22.27	22.70	19.84	19.89	19.98
Net Investment Income	0.26	0.13	0.34	0.27	0.26	0.30	0.34	0.30	0.29	--	0.31	0.27	0.19	--	0.17	0.05	0.00	--	(0.03)	--
Total Revenue	1.68	1.50	1.60	1.40	1.33	1.17	1.10	1.10	1.06	1.04	1.02	0.98	1.00	1.00	1.16	1.35	1.26	1.25	0.85	0.49
Benefits & Claims	33.71	28.72	27.99	27.57	26.54	25.38	25.12	25.04	--	--	--	--	--	--	--	--	--	--	--	--
Total Benefits & Expenses	37.89	33.32	32.25	31.29	30.10	29.76	28.67	28.40	28.38	26.81	25.22	25.31	25.02	22.32	21.63	22.45	22.68	20.99	20.07	19.41
Operating Income	1.75	(0.81)	0.40	1.10	2.01	(0.54)	0.73	1.14	1.24	(0.35)	1.21	1.44	1.72	0.12	1.17	1.22	1.29	0.06	0.63	1.24
Tax Provision	0.40	(0.25)	(0.09)	0.18	0.41	(0.22)	0.16	0.22	0.25	(0.07)	0.26	0.30	0.36	(0.06)	0.11	0.43	0.29	(0.05)	0.12	0.18
Net Income	1.19	(0.80)	0.20	0.55	1.24	(0.69)	0.48	0.68	0.74	(0.54)	0.83	0.96	1.24	(0.01)	1.20	0.70	0.93	(0.01)	1.53	0.59
Diluted EPS	9.83	(6.59)	1.62	4.51	10.30	(5.73)	3.98	5.62	6.11	(4.24)	6.71	7.66	9.87	(0.08)	9.39	5.48	7.29	(0.11)	11.84	4.55

Cash Flow Statement

(in billions USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Operating Cash Flow	1.25	(1.65)	0.97	1.27	0.33	(0.53)	1.86	1.21	0.42	(7.13)	1.25	3.18	6.69	(5.13)	8.45	0.96	0.30	(0.10)	2.84	0.36
Capital Expenditures	0.12	0.20	0.14	0.11	0.10	0.15	0.13	0.11	0.18	0.28	0.23	0.26	0.22	0.26	0.29	0.28	0.30	0.37	0.33	0.33
Free Cash Flow*	1.13	(1.85)	0.84	1.16	0.24	(0.68)	1.73	1.10	0.25	(7.42)	1.02	2.91	6.46	(5.38)	8.16	0.68	0.01	(0.47)	2.51	0.03
Investing Cash Flow	(2.55)	0.63	0.98	0.35	0.31	(0.06)	(1.47)	(1.00)	(0.41)	(0.88)	(0.58)	(0.73)	(1.29)	(1.01)	1.68	(1.02)	(0.65)	(0.10)	(4.25)	(0.71)
Financing Cash Flow	2.05	(0.17)	(0.60)	(1.83)	1.38	(2.30)	(0.77)	(0.62)	1.21	(2.44)	(1.73)	0.04	3.28	(2.36)	(1.79)	0.42	1.82	(0.71)	2.34	(0.14)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021	Q3 2020	Q2 2020	Q1 2020
Dividends Per Share	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.89	0.79	0.79	0.79	0.70	0.70	0.70	0.63	0.63	0.63	0.55